Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina.
Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia.
JAMA Ophthalmol. 2021 Feb 1;139(2):165-173. doi: 10.1001/jamaophthalmol.2020.5664.
Glaucoma-related adverse events constitute serious complications of cataract removal in infancy, yet long-term data on incidence and visual outcome remain lacking.
To identify and characterize incident cases of glaucoma and glaucoma-related adverse events (glaucoma + glaucoma suspect) among children in the Infant Aphakia Treatment Study (IATS) by the age of 10.5 years and to determine whether these diagnoses are associated with optic nerve head (ONH) and peripapillary retinal nerve fiber layer (RNFL) assessment.
DESIGN, SETTING, AND PARTICIPANTS: Analysis of a multicenter randomized clinical trial of 114 infants with unilateral congenital cataract who were aged 1 to 6 months at surgery. Data on long-term glaucoma-related status and outcomes were collected when children were 10.5 years old (July 14, 2015, to July 12, 2019) and analyzed from March 30, 2019, to August 6, 2019.
Participants were randomized at cataract surgery to either primary intraocular lens (IOL), or aphakia (contact lens [CL]). Standardized definitions of glaucoma and glaucoma suspect were created for IATS and applied for surveillance and diagnosis.
Development of glaucoma and glaucoma + glaucoma suspect in operated-on eyes up to age 10.5 years, plus intraocular pressure, axial length, RNFL (by optical coherence tomography), and ONH photographs.
In Kaplan-Meier analysis, for all study eyes combined (n = 114), risk of glaucoma after cataract removal rose from 9% (95% CI, 5%-16%) at 1 year, to 17% (95% CI, 11%-25%) at 5 years, to 22% (95% CI, 16%-31%) at 10 years. The risk of glaucoma plus glaucoma suspect diagnosis after cataract removal rose from 12% (95% CI, 7%-20%) at 1 year, to 31% (95% CI, 24%-41%) at 5 years, to 40% (95% CI, 32%-50%) at 10 years. Risk of glaucoma and glaucoma plus glaucoma suspect diagnosis at 10 years was not significantly different between treatment groups. Eyes with glaucoma (compared with eyes with glaucoma suspect or neither) had longer axial length but relatively preserved RNFL and similar ONH appearance and visual acuity at age 10 years.
Risk of glaucoma-related adverse events continues to increase with longer follow-up of children following unilateral cataract removal in infancy and is not associated with primary IOL implantation. Development of glaucoma (or glaucoma suspect) after removal of unilateral congenital cataract was not associated with worse visual acuity outcomes at 10 years.
ClinicalTrials.gov Identifier: NCT00212134.
青光眼相关的不良事件是婴儿期白内障摘除术的严重并发症,但长期的发病情况和视觉预后数据仍然缺乏。
通过对婴儿白内障治疗研究(IATS)中 10.5 岁的儿童进行分析,确定和描述青光眼和青光眼相关不良事件(青光眼+青光眼可疑)的发病情况,并确定这些诊断是否与视神经头(ONH)和视盘周围视网膜神经纤维层(RNFL)评估有关。
设计、地点和参与者:这是一项多中心、随机临床试验的分析,共有 114 名单侧先天性白内障婴儿参与,手术时年龄为 1 至 6 个月。当儿童 10.5 岁时(2015 年 7 月 14 日至 2019 年 7 月 12 日)收集长期与青光眼相关的状况和结果数据,并于 2019 年 3 月 30 日至 2019 年 8 月 6 日进行分析。
参与者在白内障手术时被随机分为原发性眼内透镜(IOL)或无晶状体(接触镜[CL])。为 IATS 创建了青光眼和青光眼可疑的标准化定义,并用于监测和诊断。
在 10.5 岁时,手术眼青光眼和青光眼+青光眼可疑的发展情况,包括眼压、眼轴长度、RNFL(光学相干断层扫描)和 ONH 照片。
在 Kaplan-Meier 分析中,对于所有研究眼(n=114),白内障切除术后青光眼的风险从 1 年时的 9%(95%CI,5%-16%)上升至 5 年时的 17%(95%CI,11%-25%),再上升至 10 年时的 22%(95%CI,16%-31%)。白内障切除术后青光眼+青光眼可疑诊断的风险从 1 年时的 12%(95%CI,7%-20%)上升至 5 年时的 31%(95%CI,24%-41%),再上升至 10 年时的 40%(95%CI,32%-50%)。10 年后,两组治疗组的青光眼和青光眼+青光眼可疑诊断风险无显著差异。青光眼眼(与青光眼可疑眼或无青光眼眼相比)的眼轴较长,但相对保留的 RNFL 和相似的 ONH 外观和视力在 10 岁时。
婴儿期单侧白内障切除术后,随着时间的延长,青光眼相关不良事件的风险持续增加,与原发性 IOL 植入无关。单侧先天性白内障切除术后青光眼(或青光眼可疑)的发生与 10 岁时的视力预后无明显相关性。
ClinicalTrials.gov 标识符:NCT00212134。